Paper7076005
Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
Maudgal DP and 2 others. Gut, 1982. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet. Papers, record 7076005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7076005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chenodeoxycholic Acid | Major topic |
| Cholelithiasis | Major topic |
| Cholesterol, Dietary | Major topic |
| Adult | |
| Aged | |
| Bile | |
| Cholesterol | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5645851 | The physicochemical basis of cholesterol gallstone formation in man. | J Clin Invest | 1968 | https://conductscience.org/library/papers/5645851 | PubMed |
| 2 | 5104113 | The solubility of cholesterol in aqueous solutions of bile salts and lecithin. | Z Ernahrungswiss | 1971 | https://conductscience.org/library/papers/5104113 | PubMed |
| 3 | 5006919 | Dissolution of cholesterol gallstones by chenodeoxycholic acid. | N Engl J Med | 1972 | https://conductscience.org/library/papers/5006919 | PubMed |
| 4 | 4117706 | Gallstone dissolution in man using chenodeoxycholic acid. | Lancet | 1972 | https://conductscience.org/library/papers/4117706 | PubMed |
| 5 | 4703231 | Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. | J Clin Invest | 1973 | https://conductscience.org/library/papers/4703231 | PubMed |
| 6 | 4580472 | Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4580472 | PubMed |
| 7 | 4746773 | Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. | Gastroenterology | 1973 | https://conductscience.org/library/papers/4746773 | PubMed |
| 8 | 4135688 | Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones. | Lancet | 1974 | https://conductscience.org/library/papers/4135688 | PubMed |
| 9 | 1152936 | Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1152936 | PubMed |
| 10 | 1178813 | Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism. | Q J Med | 1975 | https://conductscience.org/library/papers/1178813 | PubMed |
| 11 | 1183049 | Enzymatic determination of cholesterol in bile. | Clin Chim Acta | 1975 | https://conductscience.org/library/papers/1183049 | PubMed |
| 12 | 74722 | Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action. | Lancet | 1977 | https://conductscience.org/library/papers/74722 | PubMed |
| 13 | 709092 | Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones. | Br Med J | 1978 | https://conductscience.org/library/papers/709092 | PubMed |
| 14 | 435882 | Optimal timing of doses of chenic acid in patients with gall stones. | Br Med J | 1979 | https://conductscience.org/library/papers/435882 | PubMed |
| 15 | 13641241 | Phosphorus assay in column chromatography. | J Biol Chem | 1959 | https://conductscience.org/library/papers/13641241 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38318932 | Modified dietary fat intake for treatment of gallstone disease in people of any age. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/38318932 | PubMed |
| 7514975 | Pharmacological treatment of gallstones. Practical guidelines. | Drugs | 1994 | https://conductscience.org/library/papers/7514975 | PubMed |
| 7140487 | Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. | Dig Dis Sci | 1982 | https://conductscience.org/library/papers/7140487 | PubMed |
| 7009140 | Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use. | Drugs | 1981 | https://conductscience.org/library/papers/7009140 | PubMed |
| 6849734 | Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6849734 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7076005
GET https://conductscience.org/api/papers/v1/7076005/authors